Vaccine News and Research

Latest Vaccine News and Research

Freedom from the egg holds much promise for new flu vaccines

An experimental flu vaccine made in insect cells – not in eggs, where flu vaccines currently available in the United States are grown – is safe and as effective as conventional vaccines in protecting people against the flu, according to results published in the April 11 issue of the Journal of the American Medical Association .

11 Apr 2007

Rising vaccine costs put kids at risk

The American Academy of Pediatrics (AAP) is alarmed that the soaring costs of vaccines combined with lower reimbursements from insurance companies will lead to the under- immunization of the nation's children and unnecessary outbreaks of preventable diseases.

11 Apr 2007

How size matters in the retention of nanomaterials in tissue

Tiny, biodegradable particles filled with medicine may also contain answers to some of the biggest human health problems, including cancer and tuberculosis.

11 Apr 2007

Experimental flu vaccine produced using insect cells shows promise

An influenza vaccine produced with the use of insect cells appeared safe and produced an immunogenic response in healthy adults, suggesting promise as an alternative to using embryonated eggs for the development of influenza vaccine, according to a preliminary study in the April 11 issue of JAMA.

11 Apr 2007

Canada plans to acquire MVA-based smallpox vaccine

The Department of National Defence (DND) in Canada has issued a request for proposal for the acquisition of MVA based smallpox vaccines for the protection of 10,000 people and an option for protecting another 10,000 people.

11 Apr 2007

India is poised to revolutionize biotechnology

India's health biotech firms are emerging as a major global player, with growing means and know-how to produce innovative as well as generic drugs and vaccines at costs small relative to those of giant Western firms, according to ground-breaking Canadian research.

10 Apr 2007

Combination Lyme disease vaccine proteins patented

Scientists at the U.S. Department of Energy's Brookhaven National Laboratory and collaborators at Stony Brook University have received U.S. Patent Number 7,179,448 for developing chimeric, or "combination," proteins that may advance the development of vaccines and diagnostic tests for Lyme disease.

9 Apr 2007

Study shows beneficial effects of pneumococcal conjugate vaccines in children

Routine infant immunisation with pneumococcal conjugate vaccine (PCV7) has caused a 39% fall in all-cause pneumonia hospital admission rates for American children aged under two years, according to an Article published in this week's edition of The Lancet.

8 Apr 2007

Tai chi helps seniors avoid shingles

According to recent research the ancient Chinese martial art of Tai chi offers benefits beyond improving fitness and balance for older adults.

8 Apr 2007

Weak immune response critical to disease that causes most infant hospitalizations

The most common cause of infant hospitalization in the United States, respiratory syncytial virus, infects virtually all children by age two.

7 Apr 2007

Scientists decode genome of Streptococcus sanguinis

Virginia Commonwealth University researchers have decoded the genome of a bacteria normally present in the healthy human mouth that can cause a deadly heart infection if it enters the bloodstream.

7 Apr 2007

Montefiore Medical Center launches human papilloma virus clinic

The only HPV (Human Papilloma Virus) Vaccine Clinic of its kind has been launched at Montefiore Medical Center.

7 Apr 2007

Beneficial effects of pneumococcal conjugate vaccines in children re-emphasized

Routine infant immunization with pneumococcal conjugate vaccine (PCV7) has caused a 39 percent fall in all-cause pneumonia hospital admission rates for American children under 2, according to an article published in this week's edition of The Lancet .

7 Apr 2007

Roche to acquire BioVeris

BioVeris Corporation has announced that the Company has reached a definitive agreement under which Roche will acquire BioVeris for $21.50 per share in cash, or a total of approximately $600 million.

From Roche Sequencing and Life Science 5 Apr 2007

Handheld instrument assesses dental disease in minutes

Who would have guessed that when the Star Trek medical diagnostic tool known as the tricorder makes its appearance in real life, the first user might be . . . your dentist.

5 Apr 2007

St. Jude Children's Research Hospital designated as Center of Excellence for Influenza Research and Surveillance

St. Jude Children's Research Hospital has been designated one of six Centers of Excellence for Influenza Research and Surveillance funded by the National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health.

4 Apr 2007

Primary lesson of the 1918 influenza pandemic is that it is critical to intervene early

One of the persistent riddles of the deadly 1918 Spanish influenza pandemic is why it struck different cities with varying severity.

4 Apr 2007

FDA approves Twinrix

GlaxoSmithKline has announced that the U.S. Food and Drug Administration (FDA) has approved Twinrix [Hepatitis A Vaccine (Inactivated) and Hepatitis B (Recombinant) Vaccine], for an accelerated dosing schedule that consists of three doses given within three weeks followed by a booster dose at 12 months.

4 Apr 2007

Researchers document rare case of hepatitis B virus transmission

Researchers have documented a case of hepatitis B virus (HBV) transmission between two patients at a dentist's office in the United States.

4 Apr 2007

Rabies vaccine approach against HIV shows promise

Rabies, a relentless, ancient scourge, may hold a key to defeating another implacable foe: HIV. Scientists at Jefferson Medical College in Philadelphia have used a drastically weakened rabies virus to ferry HIV-related proteins into animals, in essence, vaccinating them against an AIDS-like disease.

3 Apr 2007